TandemAI

TandemAI

Biotechnology Research

New York, New York 2,919 followers

Reinventing Drug Discovery Infrastructure

About us

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. TandemAI has built its networked platform from the ground up in the U.S. and China to increase the speed of drug discovery and deliver cost-effective opportunities to its partners and to the global scientific community.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
New York, New York
Type
Privately Held
Founded
2021

Locations

Employees at TandemAI

Updates

  • View organization page for TandemAI, graphic

    2,919 followers

    The Royal Swedish Academy of Sciences has announced the 2024 Nobel Prize in Chemistry, awarding one half to David Baker for his pioneering work in computational protein design, and the other half jointly to Demis Hassabis and John M. Jumper for their contributions to protein structure prediction. This recognition underscores the exciting advancements in AI and drug discovery that align closely with our mission. At TandemAI, we are already witnessing the profound and transformative impact of innovations from Baker's lab and DeepMind. The contributions of Rosetta, AlphaFold, and other machine learning-driven efforts in protein structure prediction and design are already significant and hold great promise for the future. #NobelPrize2024 #AI #ProteinStructure #RoseTTAFold #DeepMind #AlphaFold #DrugDiscovery #DigitalBiology

    • No alternative text description for this image
  • View organization page for TandemAI, graphic

    2,919 followers

    We are excited to celebrate the 2024 Nobel Prize in Physics awarded to John J. Hopfield and Geoffrey E. Hinton for their groundbreaking contributions to neural networks and machine learning—key technologies in our progress with AI-driven drug discovery. Their revolutionary discoveries underpin the AI tools we rely on, transforming data into actionable insights that enhance patient outcomes. At TandemAI, as we continue to explore the potential of AI in drug discovery and development, their achievements inspire us to pursue even greater advancements. #NobelPrize2024 #AI #NeuralNetworks #MachineLearning #DrugDiscovery #DigitalBiology

    • No alternative text description for this image
  • View organization page for TandemAI, graphic

    2,919 followers

    We're thrilled to share TandemAI's very first publication! In collaboration with Darrin York's group at Rutgers University, we've demonstrated how a novel enhanced sampling approach can significantly improve the precision of Relative Binding Free Energy (RBFE) calculations across a broad and diverse set of protein targets and small molecule binders. RBFE calculations are highly accurate digital potency assays that are routinely used in drug discovery campaigns, and our platform TandemViz makes it simple to run these calculations at scale. Learn more at www.tandemai.com. A huge congratulations to Abir Ganguly, Hsu-Chun Tsai, and the entire, absolutely amazing, platform team. This is just the beginning - much more to come! #TandemAI #DrugDiscovery #Innovation #Teamwork #ScientificResearch #FEP

    • No alternative text description for this image
  • TandemAI reposted this

    View organization page for TandemAI, graphic

    2,919 followers

    We are in Denver, at Fall ACS! Please join Chuan Tian as he presents this afternoon about the impact of physics-based potency prediction on drug discovery at 3:35 PM MDT in Hall D – Room 1. Please also visit Evgeny Gutkin’s poster on physics-based approaches for predicting critical PharmaKinetics properties of small molecules this evening from 7 PM – 9 PM MDT in Hall A-C, poster board #631 #drugdiscovery #FEP #ACSFALL2024

    • No alternative text description for this image
  • TandemAI reposted this

    View organization page for TandemAI, graphic

    2,919 followers

    We are in Denver, at Fall ACS! Please join Chuan Tian as he presents this afternoon about the impact of physics-based potency prediction on drug discovery at 3:35 PM MDT in Hall D – Room 1. Please also visit Evgeny Gutkin’s poster on physics-based approaches for predicting critical PharmaKinetics properties of small molecules this evening from 7 PM – 9 PM MDT in Hall A-C, poster board #631 #drugdiscovery #FEP #ACSFALL2024

    • No alternative text description for this image
  • View organization page for TandemAI, graphic

    2,919 followers

    We are in Denver, at Fall ACS! Please join Chuan Tian as he presents this afternoon about the impact of physics-based potency prediction on drug discovery at 3:35 PM MDT in Hall D – Room 1. Please also visit Evgeny Gutkin’s poster on physics-based approaches for predicting critical PharmaKinetics properties of small molecules this evening from 7 PM – 9 PM MDT in Hall A-C, poster board #631 #drugdiscovery #FEP #ACSFALL2024

    • No alternative text description for this image
  • View organization page for TandemAI, graphic

    2,919 followers

    🌟 Exciting Recap! 🌟 Last week, TandemAI’s Chuan Tian delivered an insightful lecture at the inaugural Amber Free Energy Workshop at UCSD, focusing on improving the reliability of free energy calculations with enhanced sampling. The workshop featured a series of lectures and hands-on exercises designed to equip computational scientists with the best practices for conducting accurate, efficient, and reliable free energy studies. We are proud to have Dr. Tian represent TandemAI and contribute to the advancement of computational science! #FreeEnergy #MolecularDynamics #ComputationalChemistry #TandemAI #AmberWorkshop #UCSD

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for TandemAI, graphic

    2,919 followers

    We are live right now! Join now to learn more about the latest innovations in TandemViz: https://lnkd.in/eJetqZ3x

    View organization page for TandemAI, graphic

    2,919 followers

    🌟 Join Us To Learn What's New In TandemViz! We’re excited to announce a special webinar featuring the latest innovations in TandemViz. 📅 Save the Date: Tuesday, August 6th 2:00 PM (EST) 📍 Register Here On LinkedIn During the event, we'll cover new features, including expanded FEP capabilities, enhanced collaboration tools, simplified computation reuse, and easy external data uploads. Plus, get a sneak peek at the next phase of TandemViz development.   🎤 Hosted by: Frederick Parsons, Director, Head of Scientific Visualization Abir Ganguly, Director, Head of Free Energy They’ll guide you through the latest features, including how these innovations can transform your approach to drug discovery. P.S. Can't attend live? Don't worry! On-demand access will be available to registered participants.

    What's New In TandemViz

    What's New In TandemViz

    www.linkedin.com

Similar pages

Browse jobs

Funding